Yuehong Cui

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Zhi Peng, Tianshu Liu, Jia Wei et al. · Cancer Communications · 2021 · 182 citations · Full text

Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for <i>RAS</i> Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial

Wentao Tang, Li Ren, Tianshu Liu et al. · Journal of Clinical Oncology · 2020 · 114 citations · Full text

Up-regulation of Krüppel-Like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma

Jiachu Li, Xin‐Rong Yang, Haixiang Sun et al. · Gastroenterology · 2010 · 103 citations · Full text

Tumor Biology, Hepatology, Promotes Tumor Invasion +9

NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer

Yuehong Cui, Qian Li, Wei Li et al. · Frontiers in Oncology · 2021 · 78 citations · Full text

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction

Zhaoqing Tang, Yan Wang, Dan Liu et al. · Nature Communications · 2022 · 77 citations · Full text